TEDAC: Study of Prognostic Factors in Aortic Dissection Type B

Sponsor
University Hospital, Caen (Other)
Overall Status
Unknown status
CT.gov ID
NCT01984905
Collaborator
(none)
100
1
50
2

Study Details

Study Description

Brief Summary

Clinical outcomes of chronic type B aortic dissections are unknown, especially in case of false lumen expansion and risk of rupture. Data of literature give us some indications about prognosis. The 1-year survival rate is about 80%, but we deplore the 25% rate of mortality at 3 years despite follow-up.The only known predictive factors are the initial diameter of more than 4 cm and the persistence of a false lumen patent.However, actual means of follow-up do not allow to predict severe complications. The aim of the sudy is to propose a diagnostic and preventive strategy for the follow-up of chronic type B aortic dissections treated medically.

The primary objective is then to evaluate the prognostic role of 18-FDG-PET Scan in such patients in order to predict the risk of aortic diameter growth of more than 5 mm in 1 year and/or of an aortic dissections extension at 1 year. The secondary objectives are to evaluate the link between fibrosis biomarkers MMP et TIMP) and the results of imaging results (evolution of diameter and extension and results of PET-Scan imaging) Methods: 100 patients to be included in 3 years History of chronic type B aortic dissection, treated medically, evolving since more than 1 month and less than 5 years.

Expected results: Prognostic contribution of 18FDG-PET-Scan and biomarkers for the identification of patients at high risk of evolution. Elaboration of a decisional algorithm about follow-up modalities of chronic aortic dissections. Demonstration of a correlation between aortic diameter growth or aortic dissection extension and intensity of marker fixation with 18-FDG-PET-Scan.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Exploratory Study of Prognostic Factors in Aortic Dissection Type B: Role of Imaging (18F-FDG PET-Scan and Angioscan) and Biomarkers
    Study Start Date :
    Oct 1, 2013
    Anticipated Primary Completion Date :
    Dec 1, 2017
    Anticipated Study Completion Date :
    Dec 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Correlation between the increase in the aortic diameter and the intensity of 18-FDG binding (Standard Uptake Value) at 1 year [1 year]

    Secondary Outcome Measures

    1. Correlation between biomarkers of fibrosis and results of morphological and functional imaging [1 year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients over 18 years old

    • Chronic type B aortic dissection, without surgical treatment

    • Medically treated patient

    • Medical treatment since more than 1 month and less than 5 years

    • Aortic dissection localization : below left subclavian artery and alow femoral artery

    • Affiliation to a social security system

    • Patient who have given informed consent

    Exclusion Criteria:
    • History of malignant pathology

    • Aortic dissection since less than 1 month or more than 5 years

    • Inflammatory or infectious disease of the aorta

    • Uncontrolled infectious disease

    • Iodine Allergy

    • Severe renal insufficiency (cockcroft clearance <30 mL/min)

    • Patient under guardianship or curators

    • Any associated medical or psychological condition wich could compromise the patient's ability to participate in the study

    • Inability to be submitted to the study follow-up for geographical, social or psychological reasons

    • Current pregnancy or lack of effective contraception during their reproductive years

    • Suckle

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Caen University Hospital Caen France

    Sponsors and Collaborators

    • University Hospital, Caen

    Investigators

    • Principal Investigator: Ludovic BERGER, MD,PhD, Caen UH

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Caen
    ClinicalTrials.gov Identifier:
    NCT01984905
    Other Study ID Numbers:
    • 2013-A00209-36
    First Posted:
    Nov 15, 2013
    Last Update Posted:
    Nov 15, 2013
    Last Verified:
    Nov 1, 2013
    Keywords provided by University Hospital, Caen
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 15, 2013